GLUCOSE-DEPENDENT GLUT-1 EXPRESSION IN EMBRYONIC HEART
GLUCOSE-DEPENDENT GLUT-1 EXPRESSION IN EMBRYONIC HEART
批准号:
6389995
负责人:
IDA M. WASHINGTON
金额:
$25.36万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-05 至 2004-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (the applicant's description verbatim): Little is understood
regarding the mechanisms underlying cardiac dysmorphogenesis. The embryonic
heart relies on glycolytic metabolism during its early development and is thus
highly dependent on glucose as a substrate for energy production and growth.
Glucose uptake by embryonic cells is mediated primarily by the glucose
transporter, Glut-1, which is highly expressed in the embryonic heart and is
critical for delivery of glucose to embryonic heart cells for normal metabolism
and growth during organogenesis. Glut-1 glucose uptake and expression are
influenced in adult cells by glucose concentration and duration of exposure,
but little is known regarding glucose-dependent Glut-1 expression in the
embryonic heart. The central hypothesis is that the embryonic heart responds to
glucose excess and deficiency by altering cardiac morphogenesis, as manifested
at embryonic and fetal stages, glucose transport and disposition as an acute
response, cellular localization of Glut-1 as an intermediate response, and
Glut-1 mRNA expression as a chronic response. To address this hypothesis, gd
9.5 (early organogenesis) mouse embryos will be exposed in vivo and in vitro to
three glucose levels (600 mg/dl, hyperglycemia; 40 mg/dl, hypoglycemia; 150
mg/dl, normoglycemia) for three durations (0.5 hr, acute; 6 hr, intermediate;
12 hr, chronic), and hearts will be evaluated according to the following
specific aims: 1) Cardiac morphogenesis will be evaluated by gross and
histologic examination; 2) glucose transport and phosphorylation will be
calculated using [3H]2-deoxy-D-glucose, U-[14C]-glucose, and the lumped
constant. Uptake will be evaluated with and without inhibition by cytochalasin
B, and metabolites will be evaluated by NMR; 3) cellular Glut-1 localization
will be determined using immunogold labeling with EM evaluation and adenoviral
vector mediated expression of a GFP fusion tag with fluorescence microscopy; 4)
Glut-1 mRNA expression will be evaluated using in situ hybridization and
RT-qcPCR. Hyperglycemia is expected to decrease glucose uptake and
phosphorylation acutely and cause Glut-1 translocation to intracellular
membranes after intermediate exposure and decreased Glut-1 mRNA after chronic
exposure. Hypoglycemia is expected to increase glucose uptake and Glut-1
expression in the same temporal pattern. This project will produce important
information regarding the role of Glut-1 in glucose delivery to the embryonic
heart and contribute to a long-range goal of understanding embryonic heart
metabolism in response to glucose extremes, such as those occurring in the
diabetic environment, and its potential role in cardiac dysmorphogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GLUCOSE-DEPENDENT GLUT-1 EXPRESSION IN EMBRYONIC HEART
-
批准号:6159798
-
项目类别:
-
资助金额:$18.29万
-
财政年份:2000
-
负责人:IDA M. WASHINGTON
-
依托单位:
GLUCOSE-DEPENDENT GLUT-1 EXPRESSION IN EMBRYONIC HEART
-
批准号:6433833
-
项目类别:
-
资助金额:$2.58万
-
财政年份:2000
-
负责人:IDA M. WASHINGTON
-
依托单位:
GLUCOSE-DEPENDENT GLUT-1 EXPRESSION IN EMBRYONIC HEART
-
批准号:6527170
-
项目类别:
-
资助金额:$22.26万
-
财政年份:2000
-
负责人:IDA M. WASHINGTON
-
依托单位:
GLUCOSE-DEPENDENT GLUT-1 EXPRESSION IN EMBRYONIC HEART
-
批准号:6613725
-
项目类别:
-
资助金额:$12.01万
-
财政年份:2000
-
负责人:IDA M. WASHINGTON
-
依托单位:
TERATOLOGY SOCIETY 2000 MEETING--TRAVEL SUPPORT
-
批准号:6199079
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2000
-
负责人:IDA M. WASHINGTON
-
依托单位:
TERATOGENIC EFFECTS OF ORAL HYPOGLYCEMIC AGENTS
-
批准号:2201863
-
项目类别:
-
资助金额:$10.08万
-
财政年份:1994
-
负责人:IDA M. WASHINGTON
-
依托单位:
TERATOGENIC EFFECTS OF ORAL HYPOGLYCEMIC AGENTS
-
批准号:2673690
-
项目类别:
-
资助金额:$10.54万
-
财政年份:1994
-
负责人:IDA M. WASHINGTON
-
依托单位:
TERATOGENIC EFFECTS OF ORAL HYPOGLYCEMIC AGENTS
-
批准号:2403273
-
项目类别:
-
资助金额:$10.14万
-
财政年份:1994
-
负责人:IDA M. WASHINGTON
-
依托单位:
TERATOGENIC EFFECTS OF ORAL HYPOGLYCEMIC AGENTS
-
批准号:2201862
-
项目类别:
-
资助金额:$10.03万
-
财政年份:1994
-
负责人:IDA M. WASHINGTON
-
依托单位:
TERATOGENIC EFFECTS OF ORAL HYPOGLYCEMIC AGENTS
-
批准号:2201861
-
项目类别:
-
资助金额:$9.97万
-
财政年份:1994
-
负责人:IDA M. WASHINGTON
-
依托单位:
HYPOGLYCEMIA AND DIABETES-INDUCED EMBRYOPATHIES
-
批准号:3048715
-
项目类别:
-
资助金额:$2.18万
-
财政年份:1989
-
负责人:IDA M. WASHINGTON
-
依托单位:
HYPOGLYCEMIA AND DIABETES-INDUCED EMBRYOPATHIES
-
批准号:3048714
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1989
-
负责人:IDA M. WASHINGTON
-
依托单位:
海外基金